Oral contraceptives and thrombosis, From risk estimates to health impact

References

• World Health Organization Collaborative Study on cardiovascular disease and steroid hormone contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575–82.
   Google Scholar
• World Health Organization Collaborative Study on cardiovascular disease and steroid hormone contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582–8.
   PubMed Web of Science ®Google Scholar
• Poulter NR, Farley RMM, Chang CL, Marmot MG, Meirik O. Safety of combined oral contraceptive pills [Letter]. Lancet 1996; 347: 547.
   Google Scholar
• Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593–6.
   PubMed Web of Science ®Google Scholar
• Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of ideopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589–93.
   Google Scholar
• Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case- control study. BMJ 1996; 312: 83–8.
   Google Scholar
• Lewis AM, Heinemann LAJ, MacRae KD, Bruppacher R, Spitzer WO. The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational research. Contraception 1996; 54: 5–13.
   Google Scholar
• Mills A. Combined oral contraception and the risk of venous thromboembolism. Hum Reprod 1997; 12: 2595–8.
   PubMed Web of Science ®Google Scholar
• Skjeldestad FE. Increased number of induced abortions in Norway after the media coverage of adverse vascular events from the use of third-generation oral contraceptives. Contraception 1997; 55: 11–14.
   PubMed Web of Science ®Google Scholar
• Ramsay S. UK ‘pill scare’ led to abortion increase. Lancet 1996; 347: 1109.
   PubMed Web of Science ®Google Scholar
• Milsom I, Odlind V Hedberg C, Lidegaard Ø. Alarming increase in the number of abortions. Does fear of thrombosis limit the use of oral contraceptives?. Läkertidningen 1997; 94: 4731–6.
   Google Scholar
• Statistics Finland: Statistical yearbook of Finland 1997; 92: 440.
   Google Scholar
• Lidegaard Ø, Milsom I. The pill. The controversy continues. Acta Obstet Gynecol Scand 1996; 75: 93–7.
   Google Scholar
• Lidegaard Ø, Milsom I. Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies. Contraception 1996; 53: 135–9.
   Google Scholar
• Westhoff CL. Oral contraceptives and venous thromboembolism: Should epidemiologic associations drive clinical decision making? Contraception 1996; 54: 1–3.
   PubMed Web of Science ®Google Scholar
• Speroff L. Oral contraceptives and venous thromboembolism. Int J Gynaecol Obstet 1996; 54: 45–50.
   Google Scholar
• Heinemann LAJ, Lewis M, Assmann A, Cravens L, Guggenmoos-Holzmann I. Could preferential prescribing and referral behavior of physicians explain the elevated thrombotic risk found to be associated with third generation oral contraceptives? Drug Saf 1996; 5: 285–94.
   Google Scholar
• Farley TMM, Meirik O, Poulter NR, Chang CL, Marmot MG. Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies. Contraception 1996; 54: 193–5.
   Google Scholar
• Vandenbroucke JP, Rosendaal FR. End of the line for ‘third-generation-pill’ controversy? Lancet 1997; 349: 1113–14.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KWM, Rosendaal FR. Third-generation oral contraceptives and deep venous thrombosis: From epidemiologic controversy to new insight in coagulation. Am J Obstet Gynecol 1997; 177: 887–91.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø. The influence of thrombotic risk factors when oral contraceptives are prescribed. Acta Obstet Gynecol Scand 1997; 76: 252–60.
   Google Scholar
• Lidegaard Ø, Edström B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998; 57: 291–301.
   Google Scholar
• Herings RMC, Boer DA, Urquhart J, Leufkens HGM. Non-causal explanations for the increased risk of venous thromboembolism among users of third-generation oral contraceptives. Pharmacoepidemiool Drug Safety 1996; 5: S88.
   Google Scholar
• Farmer RDT, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349: 83–8.
   Google Scholar
• Vandenbroucke JP, Bloemenkamp KWM, Helmerhorst FM, Rosendaal FR. Mortality from venous thromboembolism and myocardial infarction in young women in The Netherlands. Lancet 1996; 348: 401–2.
   PubMed Web of Science ®Google Scholar
• Thomas SHL. Mortality from venous thromboembolism and myocardial infarction in young adults in England and Wales. Lancet 1996; 348: 402.
   PubMed Web of Science ®Google Scholar
• Andersen BS, Steffensen FH, Sorensen HT, Nielsen GL, Olsen J. The cumulative incidence of venous thromboembolism during pregnancy and puerperium – An 11 year Danish population-based study of 63,300 pregnancies. Acta Obstet Gynecol Scand 1998; 77: 170–3.
   Google Scholar
• Rosing J, Tans G, Nicolaes GAF, Thomassen MCLGD, Oerle RV Ploeg PMENVD et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol 1997; 97: 233–8.
   Google Scholar
• Douketis JD, Ginsberg JS, Holbrook A, Crowther M, Duku EK, Burrows RF. A reevaluation of the risks for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. Arch Int Med 1997; 157: 1522–30.
   Google Scholar
• Lewis MA, Spitzer WO, Heinemann LAJ, MacRae KD, Bruppacher R, Thorogood M. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. BmJ 1996; 312: 88–90.
   PubMed Web of Science ®Google Scholar
• Lewis M, Heinemann LAJ, Spitzer WO, MacRae KD, Bruppacher R. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Contraception 1997; 56: 129–40.
   Google Scholar
• Jick H, Jick SS, Myers MW, Vasilakis C. Risk of acute myocardial infarction and low-dose combined oral contraceptives. [Letter]. Lancet 1996; 347: 627–8.
   PubMed Web of Science ®Google Scholar
• WHO. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet 1997; 349: 1202–9.
   PubMedGoogle Scholar
• Lidegaard Ø, Edström B. Oral contraceptives and myocardial infarction. A case-control study. [Abstract]. Eur J Contraception Reprod Health Care, suppl 1, 72–3.
   Google Scholar
• WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet 1996; 348: 498–505.
   Google Scholar
• Heinemann LAJ, Lewis MA, Thorogood M, Spitzer WO, Guggenmoss-Holzmann I, Bruppacher R. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from international study on oral contraceptives and health of young women. BMJ 1997; 315: 1502–4.
   Google Scholar
• Lidegaard Ø, Kreiner S. Cerebral thrombosis and oral contraceptives. Contraception 1998; 57: 303–14.
   Google Scholar
• Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996; 335: 8–15.
   PubMed Web of Science ®Google Scholar
• Schwartz SM, Siscovick DS, Longstreth WT et al. Use of low-dose oral contraceptives and stroke in young women. Ann Int Med 1997; 127: 596–603.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø. Thrombotic diseases in young women and the influence from oral contraceptives. Am J Obstet Gynecol 1998, in press.
   Google Scholar
• WHO. Cardiovascular disease and steroid hormone contraception. WHO Technical Report Series 877. Geneva, 1998.
   Google Scholar